Impact of pulmonary artery pressure on recurrence after catheter ablation in patients with atrial fibrillation

Front Cardiovasc Med. 2023 Sep 4:10:1187774. doi: 10.3389/fcvm.2023.1187774. eCollection 2023.

Abstract

Background: The pulmonary veins play a major role in the pathogenesis of atrial fibrillation (AF) and may be affected by cardiac remodeling due to pulmonary vascular dysfunction. It remains to be determined whether pulmonary artery pressure (PAP) is associated with the recurrence of AF after radiofrequency catheter ablation (RFCA).

Methods: Consecutive patients with paroxysmal and persistent AF who underwent RFCA, including wide circumferential pulmonary vein isolation, were analyzed. Systolic PAP was measured using transthoracic echocardiography, and clinical outcomes were compared between patients with PAP <35 mmHg and those with PAP ≥35 mmHg.

Results: Among 2,379 patients (mean age 56.7 ± 10.6 years, 77% men), 1,893 (79.6%) had PAP <35 mmHg and 486 (20.4%) had PAP ≥35 mmHg. During the median follow-up of 25.4 months, in patients with paroxysmal AF (n = 1,294), the recurrence rate was significantly greater in the PAP ≥35 mmHg group than in the PAP <35 mmHg group (35.1% vs. 23.8%, log-rank p = 0.008). However, in patients with persistent AF (n = 1,085), the recurrence rate was not significantly different between the two groups (52.2% vs. 49.7%, log-rank p = 0.409). Multivariate analysis using Cox regression showed that PAP ≥35 mmHg was significantly associated with clinical recurrence (hazard ratio 1.19, 95% confidence interval 1.02-1.40, p = 0.027).

Conclusion: This study showed that a higher PAP was associated with an increased risk of recurrence after RFCA in patients with paroxysmal AF, suggesting a mechanism by which a pulmonary vascular pathology may cause impairment of the pulmonary veins and remodeling of the left atrium.

Keywords: atrial fibrillation; atrial remodeling; pulmonary atrial pressure; radiofrequency catheter ablation; recurrence.

Grants and funding

This work was supported by a Korea University Grant (J-IC), a grant from Korea University Anam Hospital, Seoul, Republic of Korea (J-IC), and, in part, by grants from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science and ICT (2021R1A2C2011325 to J-IC). The funders had no role in data collection, analysis, interpretation, trial design, patient recruitment, or any aspect pertaining to the study.